has been cited by the following articles in journals that are participating in CrossRef's forward linking service: | ||
| A randomised controlled trial into the effects of food on ADHD Lidy M.J. Pelsser, Klaas Frankena, Jan Toorman, Huub F.J. Savelkoul, Rob Rodrigues Pereira, and Jan K. Buitelaar European Child & Adolescent Psychiatry (2008) Link to Article | ||
| Reboxetine versus methylphenidate in treatment of children and adolescents with attention deficit-hyperactivity disorder Fariba Arabgol, Leily Panaghi, and Paria Hebrani European Child & Adolescent Psychiatry (2008) Link to Article | ||
| Biodistribution and radiation dosimetry of the norepinephrine transporter radioligand (S,S)-[18F]FMeNER-D2: a human whole-body PET study Akihiro Takano, Christer Halldin, Andrea Varrone, Per Karlsson, Nils Sjöholm, James B. Stubbs, Magnus Schou, Anu J. Airaksinen, Johannes Tauscher, and Balázs Gulyás European Journal of Nuclear Medicine and Molecular Imaging (2008) 35: 630 Link to Article | ||
| An Open-Label Trial of Reboxetine in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Mehdi Tehrani-Doost, Shirin Moallemi, and Zahra Shahrivar Journal of Child and Adolescent Psychopharmacology (2008) 18: 179 Link to Article | ||
| Psychopharmacological and Other Treatments in Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and Practice Jaswinder K. Ghuman, L. Eugene Arnold, and Bruno J. Anthony Journal of Child and Adolescent Psychopharmacology (2008) 18: 413 Link to Article | ||
| Switching from Neurostimulant Therapy to Atomoxetine in Children and Adolescents with Attention-Deficit Hyperactivity Disorder Suyash Prasad and Chris Steer Pediatric Drugs (2008) 10: 39 Link to Article | ||
| A Modeled Economic Evaluation Comparing Atomoxetine with Stimulant Therapy in the Treatment of Children with Attention-Deficit/Hyperactivity Disorder in the United Kingdom Suzi Cottrell, Dominic Tilden, Paul Robinson, Jay Bae, Jorge Arellano, Eric Edgell, Mike Aristides, and Kristina S. Boye Value in Health (2008) 11: 376 Link to Article | ||
| ‘I Bambini e le Droghe’: The Right to Ritalin vs the Right to Childhood in Italy Giovanni Frazzetto, Sinéad Keenan, and Ilina Singh BioSocieties (2007) 2 Link to Article | ||
| Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents Mark L Wolraich, Laura McGuinn, and Melissa Doffing Drug Safety (2007) 30: 17 Link to Article | ||
| Drug and non-drug treatments of children with ADHD and tic disorders Yann Poncin, Denis G. Sukhodolsky, Joseph McGuire, and Lawrence Scahill European Child & Adolescent Psychiatry (2007) 16: 78 Link to Article | ||
| Emerging drugs for attention-deficit/hyperactivity disorder Richard H Weisler Expert Opinion on Emerging Drugs (2007) 12: 423 Link to Article | ||
| Review of long-acting stimulants in the treatment of attention deficit hyperactivity disorder Richard H Weisler Expert Opinion on Pharmacotherapy (2007) 8: 745 Link to Article | ||
| Quetiapine Addition in Methylphenidate Treatment-Resistant Adolescents with Comorbid ADHD, Conduct/Oppositional-Defiant Disorder, and Aggression: A Prospective, Open-Label Study William G. Kronenberger, Ann L. Giauque, Deborah E. Lafata, Bradley N. Bohnstedt, Laura E. Maxey, and David W. Dunn Journal of Child and Adolescent Psychopharmacology (2007) 17: 334 Link to Article | ||
| Efficacy and Safety of Atomoxetine in Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depression Mark E. Bangs, Graham J. Emslie, Thomas J. Spencer, Janet L. Ramsey, Christopher Carlson, Eric J. Bartky, Joan Busner, David A. Duesenberg, Paras Harshawat, and Stuart L. Kaplan Journal of Child and Adolescent Psychopharmacology (2007) 17: 407 Link to Article | ||
| Open-Label Amantadine in Children with Attention-Deficit/Hyperactivity Disorder Renato Donfrancesco, Dario Calderoni, and Benedetto Vitiello Journal of Child and Adolescent Psychopharmacology (2007) 17: 657 Link to Article | ||
| Effects of Atomoxetine on Growth in Children with Attention-Deficit/Hyperactivity Disorder Following up to Five Years of Treatment Thomas J. Spencer, Christopher J. Kratochvil, R. Bart Sangal, Keith E. Saylor, Charles E. Bailey, David W. Dunn, Daniel A. Geller, Charles D. Casat, Robert S. Lipetz, and Rakesh Jain Journal of Child and Adolescent Psychopharmacology (2007) 17: 689 Link to Article | ||
| Effectiveness of Atomoxetine and Quality of Life in Children with Attention-Deficit/Hyperactivity Disorder as Perceived by Patients, Parents, and Physicians in an Open-Label Study Peter M. Wehmeier, Ralf W. Dittmann, Alexander Schacht, Anette Minarzyk, Martin Lehmann, Kathrin Sevecke, and Gerd Lehmkuhl Journal of Child and Adolescent Psychopharmacology (2007) 17: 813 Link to Article | ||
| Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder &NA; Journal of the American Academy of Child & Adolescent Psychiatry (2007) 46: 894 Link to Article | ||
| Atomoxetine Treatment for Pediatric Patients With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety Disorder DANIEL GELLER, CRAIG DONNELLY, FRANK LOPEZ, RICHARD RUBIN, JEFFREY NEWCORN, VIRGINIA SUTTON, ROSALIE BAKKEN, MARTIN PACZKOWSKI, DOUGLAS KELSEY, and CALVIN SUMNER Journal of the American Academy of Child & Adolescent Psychiatry (2007) 46: 1119 Link to Article | ||
| The Neuropsychology of Amphetamine and Opiate Dependence: Implications for Treatment Karen D Ersche and Barbara J Sahakian Neuropsychology Review (2007) 17: 317 Link to Article | ||
| Pharmacologic Treatment of Attention-Deficit/Hyperactivity Disorder: Efficacy, Safety and Mechanisms of Action Steven R. Pliszka Neuropsychology Review (2007) 17: 61 Link to Article | ||
| Testing Computational Models of Dopamine and Noradrenaline Dysfunction in Attention Deficit/Hyperactivity Disorder Michael J Frank, Amy Santamaria, Randall C O'Reilly, and Erik Willcutt Neuropsychopharmacology (2007) 32: 1583 Link to Article | ||
| Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents—meta-analysis and meta-regression analysis Jackie Y. W. Cheng, Ronald Y. L. Chen, John S. N. Ko, and Emil M. L. Ng Psychopharmacology (2007) 194: 197 Link to Article | ||
| Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data Joseph Biederman, Thomas J. Spencer, Jeffrey H. Newcorn, Haitao Gao, Denái R. Milton, Peter D. Feldman, and Michael M. Witte Psychopharmacology (2007) 190: 31 Link to Article | ||
| Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder Bing Wang, Yufeng Wang, Rulun Zhou, Jun Li, Qiujin Qian, Li Yang, Lili Guan, and Stephen V. Faraone American Journal of Medical Genetics Part B Neuropsychiatric Genetics (2006) 141b: 130 Link to Article | ||
| Agreement between parent and child report of quality of life in children with attention-deficit/hyperactivity disorder A. F. Klassen, A. Miller, and S. Fine Child Care Health and Development (2006) 32: 397 Link to Article | ||
| Treatment of attention deficits in neurological disorders Elizabeth Coulthard, Victoria Singh-Curry, and Masud Husain Current Opinion in Neurology (2006) 19: 613???618 Link to Article | ||
| Comorbid oppositional defiant disorder and the risk of relapse during 9 months of atomoxetine treatment for attention-deficit/hyperactivity disorder Philip Hazell, Shuyu Zhang, Tomasz Wolańczyk, Joanne Barton, Mats Johnson, Alessandro Zuddas, Marina Danckaerts, Andrula Ladikos, David Benn, and Roni Yoran-Hegesh European Child & Adolescent Psychiatry (2006) 15: 105 Link to Article | ||
| A comparison of North American versus non-North American ADHD study populations Jan K. Buitelaar, Joanne Barton, Marina Danckaerts, Edgar Friedrichs, Christopher Gillberg, Philip L. Hazell, Hans Hellemans, Mats Johnson, Luuk J. Kalverdijk, and Gabriele Masi European Child & Adolescent Psychiatry (2006) 15: 177 Link to Article | ||
| Treatment of ADHD with French maritime pine bark extract, Pycnogenol® Jana Trebatická, Soňa Kopasová, Zuzana Hradečná, Kamil Činovský, Igor Škodáček, Ján Šuba, Jana Muchová, Ingrid Žitňanová, Iweta Waczulíková, and Peter Rohdewald European Child & Adolescent Psychiatry (2006) 15: 329 Link to Article | ||
| Study design, baseline patient characteristics and intervention in a cross-cultural framework: results from the ADORE study Ulrich Preuss, Stephen J. Ralston**, Gisli Baldursson, Bruno Falissard, Maria J. Lorenzo, Rob Rodrigues Pereira, Laurens Vlasveld, and David Coghill European Child & Adolescent Psychiatry (2006) 15: i4 Link to Article | ||
| Cross-cultural reliability and validity of ADHD assessed by the ADHD Rating Scale in a pan-European study Manfred Döpfner, Hans-Christoph Steinhausen, David Coghill, Søren Dalsgaard, Lynne Poole, Stephen J. Ralston**, and Aribert Rothenberger European Child & Adolescent Psychiatry (2006) 15: i46 Link to Article | ||
| Discriminative-Stimulus, Self-Reported, Performance, and Cardiovascular Effects of Atomoxetine in Methylphenidate-Trained Humans. Joshua A. Lile, William W. Stoops, Todd M. Durell, Paul E. A. Glaser, and Craig R. Rush Experimental and Clinical Psychopharmacology (2006) 14: 136 Link to Article | ||
| Impact of atomoxetine on health-related quality of life and functional status in patients with ADHD Louis S Matza, Maria N Stoeckl, Jodi M Shorr, and Joseph A Johnston Expert Review of Pharmacoeconomics & Outcomes Research (2006) 6: 379 Link to Article | ||
| Psychopharmacology Notes. Nonstimulant Medications for the Treatment of ADHD Adrienne Rains and Lawrence Scahill Journal of Child and Adolescent Psychiatric Nursing (2006) 19: 44 Link to Article | ||
| Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms in Children with Pervasive Developmental Disorders: APilot Study Pieter W. Troost, Mark-Peter Steenhuis, Hanneke G. Tuynman-Qua, Luuk J. Kalverdijk, Jan K. Buitelaar, Ruud B. Minderaa, and Pieter J. Hoekstra Journal of Child and Adolescent Psychopharmacology (2006) 16: 611 Link to Article | ||
| Open-Label Atomoxetine for Attention-Deficit/ Hyperactivity Disorder Symptoms Associated with High-Functioning Pervasive Developmental Disorders David J. Posey, Ryan E. Wiegand, Jennifer Wilkerson, Melissa Maynard, Kimberly A. Stigler, and Christopher J. McDougle Journal of Child and Adolescent Psychopharmacology (2006) 16: 599 Link to Article | ||
| Placebo-Controlled Study of the Effects of Atomoxetine on Bladder Control in Children With Nocturnal Enuresis Calvin R. Sumner, Kory J. Schuh, Virginia K. Sutton, Robert Lipetz, and Douglas K. Kelsey Journal of Child and Adolescent Psychopharmacology (2006) 16: 699 Link to Article | ||
| Atomoxetine Treatment in Children and Adolescents with Attention-Deficit Hyperactivity Disorder: What Are the Long-Term Health-Related Quality-of-Life Outcomes? Amy R. Perwien, Christopher J. Kratochvil, Douglas E. Faries, Brigette S. Vaughan, Thomas Spencer, and Ronald T. Brown Journal of Child and Adolescent Psychopharmacology (2006) 16: 713 Link to Article | ||
| Decreased Use of Clonidine Following Treatment With Atomoxetine in Children With ADHD Joseph A. Johnston, Wenyu Ye, David L. Van Brunt, Gerhardt Pohl, and Calvin R. Sumner Journal of Clinical Psychopharmacology (2006) 26: 389 Link to Article | ||
| ADHD FRANK A. L??PEZ Journal of Developmental & Behavioral Pediatrics (2006) 27: 410 Link to Article | ||
| The Texas Children's Medication Algorithm Project STEVEN R. PLISZKA, M. LYNN CRISMON, CARROLL W. HUGHES, C. KEITH CORNERS, GRAHAM J. EMSLIE, PETER S. JENSEN, JAMES T. McCRACKEN, JAMES M. SWANSON, and MOLLY LOPEZ Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 642 Link to Article | ||
| Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity Disorder CHRISTOPHER J. KRATOCHVIL, TIMOTHY E. WILENS, LAURENCE L. GREENHILL, HAITAO GAO, KURT D. BAKER, PETER D. FELDMAN, and DOUGLAS L. GELOWITZ Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 919 Link to Article | ||
| Atomoxetine for Hyperactivity in Autism Spectrum Disorders L. EUGENE ARNOLD, MICHAEL G. AMAN, AMELIA M. COOK, ANDREA N. WITWER, KRISTY L. HALL, SUSAN THOMPSON, and YASER RAMADAN Journal of the American Academy of Child & Adolescent Psychiatry (2006) 45: 1196 Link to Article | ||
| Atomoxetine: a novel treatment for child and adult ADHD Marcialee Ledbetter Neuropsychiatric Disease and Treatment (2006) 2: 455 Link to Article | ||
| Comparison of the Inhibitory and Excitatory Effects of ADHD Medications Methylphenidate and Atomoxetine on Motor Cortex Donald L Gilbert, Keith R Ridel, Floyd R Sallee, Jie Zhang, Tara D Lipps, and Eric M Wassermann Neuropsychopharmacology (2006) 31: 442 Link to Article | ||
| Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
Nicholas Seneca, Balázs Gulyás, Andrea Varrone, Magnus Schou, Anu Airaksinen, Johannes Tauscher, Francois Vandenhende, William Kielbasa, Lars Farde, and Robert B. Innis Psychopharmacology (2006) 188: 119 Link to Article | ||
| Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder Atilla Turgay Therapy (2006) 3: 19 Link to Article | ||
| Atomoxetine in the treatment of children, adolescents and adults with attention deficit hyperactivity disorder Atilla Turgay Therapy (2006) 3: 19 Link to Article | ||
| Clinical Pharmacokinetics of Atomoxetine John-Michael Sauer, Barbara J Ring, and Jennifer W Witcher Clinical Pharmacokinetics (2005) 44: 571 Link to Article | ||
| Detecting Treatment Emergent Adverse Events in Clinical Trials Joachim F Wernicke, Douglas Faries, Den??i Milton, and Karen Weyrauch Drug Safety (2005) 28: 1057 Link to Article | ||
| The scientific foundation for understanding attention-deficit/hyperactivity disorder as a valid psychiatric disorder Stephen V. Faraone European Child & Adolescent Psychiatry (2005) 14: 1 Link to Article | ||
| The safety of non-stimulant agents for the treatment of attention-deficit hyperactivity disorder Sunke Himpel, Tobias Banaschewski, Cord-Alexander Heise, and Aribert Rothenberger Expert Opinion on Drug Safety (2005) 4: 311 Link to Article | ||
| Do adrenergically active drugs have a role in the first-line treatment of attention-deficit/hyperactivity disorder? Philip Hazell Expert Opinion on Pharmacotherapy (2005) 6: 1989 Link to Article | ||
| Safety, efficacy and extended duration of action of mixed amphetamine salts extended-release capsules for the treatment of ADHD Richard H Weisler Expert Opinion on Pharmacotherapy (2005) 6: 1003 Link to Article | ||
| Quality of life of children with attention deficit hyperactivity disorder Anne F Klassen Expert Review of Pharmacoeconomics & Outcomes Research (2005) 5: 95 Link to Article | ||
| ADHD rating scale IV: psychometric properties from a multinational study as clinician-administered instrument S. Zhang, D.E. Faries, M. Vowles, and D. Michelson International Journal of Methods in Psychiatric Research (2005) 14: 186 Link to Article | ||
| Atomoxetine Treatment in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder Jeffrey H Newcorn, Thomas J Spencer, Joseph Biederman, Den??i R Milton, and David Michelson Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 240 Link to Article | ||
| A Randomized, Placebo-Controlled Study of Once-Daily Atomoxetine in the School Setting in Children With ADHD Margaret Weiss, Rosemary Tannock, Christopher Kratochvil, David Dunn, Jesus Velez-Borras, Christine Thomason, Roy Tamura, Douglas Kelsey, Linda Stevens, and Albert J Allen Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 647 Link to Article | ||
| The Answerable Question and a Hierarchy of Evidence John Hamilton Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 596 Link to Article | ||
| Atomoxetine Alone or Combined With Fluoxetine for Treating ADHD With Comorbid Depressive or Anxiety Symptoms Christopher J Kratochvil, Jeffrey H Newcorn, L Eugene Arnold, David Duesenberg, Graham J Emslie, Humberto Quintana, Elias H Sarkis, Karen Dineen Wagner, Haitao Gao, and David Michelson Journal of the American Academy of Child & Adolescent Psychiatry (2005) 44: 915 Link to Article | ||
| Parent-Proxy EQ-5D Ratings of Children with Attention-Deficit Hyperactivity Disorder in the US and the UK Louis S Matza, Kristina Secnik, Sally Mannix, and F Randy Sallee PharmacoEconomics (2005) 23: 777 Link to Article | ||
| Psychometric validation of the child health questionnaire (CHQ) in a sample of children and adolescents with attention-deficit/hyperactivity disorder Anne M. Rentz, Louis S. Matza, Kristina Secnik, Andrine Swensen, and Dennis A. Revicki Quality of Life Research (2005) 14: 719 Link to Article | ||
| Recent Advances in Pharmacotherapies for the Externalizing Disorders Ronald T. Brown School Psychology Quarterly (2005) 20: 118 Link to Article | ||
| Review of new compounds available in Australia for the treatment of attention-deficit hyperactivity disorder Philip Hazell Australasian Psychiatry (2004) 12: 369 Link to Article | ||
| Atomoxetine in Children and Adolescents with ADHD Abel Ickowicz Child and Adolescent Psychopharmacology News (2004) 9: 7 Link to Article | ||
| Atomoxetine Tim Yates Child and Adolescent Psychopharmacology News (2004) 9: 1 Link to Article | ||
| New Formulations of Stimulants for Attention-Deficit Hyperactivity Disorder Daniel F Connor and Ronald J Steingard CNS Drugs (2004) 18: 1011 Link to Article | ||
| ???Pay attention??? to stimulants in attention-deficit hyperactivity disorder when other psychiatric disorders exist &NA; Drugs & Therapy Perspectives (2004) 20: 12 Link to Article | ||
| Atomoxetine in the treatment of attention deficit hyperactivity disorder Christopher J Kratochvil, Brigette S Vaughan, Joan M Daughton, Michelle L Mayfield-Jorgensen, and William J Burke Expert Review of Neurotherapeutics (2004) 4: 601 Link to Article | ||
| Aggression and disruptive behavior disorders in children and adolescents Atilla Turgay Expert Review of Neurotherapeutics (2004) 4: 623 Link to Article | ||
| Changes in Symptoms and Adverse Events After Discontinuation of Atomoxetine in Children and Adults With Attention Deficit/Hyperactivity Disorder Joachim F. Wernicke, Lenard Adler, Thomas Spencer, Scott A. West, Albert J. Allen, John Heiligenstein, Den??i Milton, Dustin Ruff, W. Jeffrey Brown, and Douglas Kelsey Journal of Clinical Psychopharmacology (2004) 24: 30 Link to Article | ||
| Effects of Once-Daily Osmotic-Release Methylphenidate on Blood Pressure and Heart Rate in Children with Attention-Deficit/Hyperactivity Disorder Timothy E. Wilens, Joseph Biederman, and Marc Lerner Journal of Clinical Psychopharmacology (2004) 24: 36 Link to Article | ||
| Improvement in Health-Related Quality of Life in Children with ADHD AMY R. PERWIEN, DOUGLAS E. FARIES, CHRISTOPHER J. KRATOCHVIL, CALVIN R. SUMNER, DOUGLAS K. KELSEY, and ALBERT J. ALLEN Journal of Developmental & Behavioral Pediatrics (2004) 25: 264 Link to Article | ||
| The Link Between Health-Related Quality of Life and Clinical Symptoms Among Children with Attention-Deficit Hyperactivity Disorder LOUIS S. MATZA, ANNE M. RENTZ, KRISTINA SECNIK, ANDRINE R. SWENSEN, DENNIS A. REVICKI, DAVID MICHELSON, THOMAS SPENCER, JEFFREY H. NEWCORN, and CHRISTOPHER J. KRATOCHVIL Journal of Developmental & Behavioral Pediatrics (2004) 25: 166 Link to Article | ||
| Adolescents with Attention-Deficit/Hyperactivity Disorder: An Overview of Empirically Based Treatments RUSSELL A. BARKLEY Journal of Psychiatric Practice (2004) 10: 39 Link to Article | ||
| Association of Norepinephrine Transporter Gene With Methylphenidate Response LI YANG, YU-FENG WANG, JUN LI, and STEPHEN V FARAONE Journal of the American Academy of Child & Adolescent Psychiatry (2004) 43: 1154 Link to Article | ||
| Relapse Prevention in Pediatric Patients With ADHD Treated With Atomoxetine: A Randomized, Double-Blind, Placebo-Controlled Study DAVID MICHELSON, JAN K BUITELAAR, MARINA DANCKAERTS, CHRISTOPHER GILLBERG, THOMAS J SPENCER, ALESSANDRO ZUDDAS, DOUGLAS E FARIES, SHUYU ZHANG, and JOSEPH BIEDERMAN Journal of the American Academy of Child & Adolescent Psychiatry (2004) 43: 896 Link to Article | ||
| Evaluation of the Reinforcing Effects of Monoamine Reuptake Inhibitors Under a Concurrent Schedule of Food and I.V. Drug Delivery in Rhesus Monkeys Maciej Gasior, Jack Bergman, Mary Jeanne Kallman, and Carol A Paronis Neuropsychopharmacology (2004) Link to Article | ||
| Therapeutic Monitoring of Antidepressants in the Era of Pharmacogenetics Studies C. B. Eap, E. Jaquenoud Sirot, and P. Baumann Therapeutic Drug Monitoring (2004) 26: 152 Link to Article | ||
| Assessment of Health-Related Quality of Life in Children: A Review of Conceptual, Methodological, and Regulatory Issues Louis S. Matza, Andrine R. Swensen, Emuella M. Flood, Kristina Secnik, and Nancy Kline Leidy Value in Health (2004) 7: 79 Link to Article | ||
Katie Daley Current Opinion in Pediatrics (2003) 15: 216 Link to Article | ||
| Cardiovascular Effects of Atomoxetine in Children, Adolescents, and Adults Joachim F Wernicke, Douglas Faries, Donald Girod, Jeffrey W Brown, Haitao Gao, Douglas Kelsey, Humberto Quintana, Robert Lipetz, David Michelson, and John Heiligenstein Drug Safety (2003) 26: 729 Link to Article | ||
| New approaches to developing antidepressants by enhancing monoaminergic neurotransmission Frank P Bymaster, Robert K McNamara, and Pierre V Tran Expert Opinion on Investigational Drugs (2003) 12: 531 Link to Article | ||
| Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder Christopher J Kratochvil, Brigette S Vaughan, Martin J Harrington, and William J Burke Expert Opinion on Pharmacotherapy (2003) 4: 1165 Link to Article | ||
| Bupropion for attentiondeficit hyperactivity and comorbid disorders W Burleson Daviss, Raymond J Pan, and James M Perel Expert Review of Neurotherapeutics (2003) 3: 9 Link to Article | ||
| Costs associated with attention deficit hyperactivity disorder: overview and future projections James P Guevara and David S Mandell Expert Review of Pharmacoeconomics & Outcomes Research (2003) 3: 201 Link to Article | ||
| Methodological Issues and Controversies in Clinical Trials with Child and Adolescent Patients with Bipolar Disorder: Report of a Consensus Conference Gabrielle A. Carlson, Peter S. Jensen, Robert L. Findling, Roger E. Meyer, Joseph Calabrese, Melissa P. DelBello, Graham Emslie, Laurie Flynn, Frederick Goodwin, and Martha Hellander Journal of Child and Adolescent Psychopharmacology (2003) 13: 13 Link to Article | ||
| Ten-Year Review of Rating Scales. V: Scales Assessing Attention-Deficit/Hyperactivity Disorder BRENT R. COLLETT, JENEVA L. OHAN, and KATHLEEN M. MYERS Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 1015 Link to Article | ||
| Review of Safety Assessment Methods Used in Pediatric Psychopharmacology LAURENCE L. GREENHILL, BENEDETTO VITIELLO, MARK A. RIDDLE, PRUDENCE FISHER, ERIN SHOCKEY, JOHN S. MARCH, JEROME LEVINE, JANE FRIED, HOWARD ABIKOFF, and JULIE M. ZITO Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 627 Link to Article | ||
| ATOMOXETINE AND PREGNANCY Norman E. Alessi and Scott Spalding Journal of the American Academy of Child & Adolescent Psychiatry (2003) 42: 883 Link to Article | ||
| A review of the biological bases of ADHD: What have we learned from imaging studies? Sarah Durston Mental Retardation and Developmental Disabilities Research Reviews (2003) 9: 184 Link to Article | ||
| Psychiatric Comorbidities in Children with Attention Deficit Hyperactivity Disorder Steven R Pliszka Pediatric Drugs (2003) 5: 741 Link to Article | ||
| Atomoxetine: A Selective Norepinephrine Reuptake Inhibitor for the Treatment of Attention-Deficit/Hyperactivity Disorder. Rafael A. Rivas-Vazquez Professional Psychology Research and Practice (2003) 34: 666 Link to Article | ||
| First New ADHD Treatment in 30 Years Lynn Wimett and Gary Laustsen The Nurse Practitioner (2003) 28: 50 Link to Article | ||
Kelly Kirby, Lori Rutman, and Henry Bernstein Current Opinion in Pediatrics (2002) 14: 236 Link to Article | ||
Dave Coghill Current Opinion in Psychiatry (2002) 15: 361 Link to Article | ||
| New drugs for treatment of attention-deficit/hyperactivity disorder Bowen Chung, Alejandra R Suzuki, and James J McGough Expert Opinion on Emerging Drugs (2002) 7: 269 Link to Article | ||
| Atomoxetine and Methylphenidate Treatment in Children With ADHD: A Prospective, Randomized, Open-Label Trial CHRISTOPHER J. KRATOCHVIL, JOHN H. HEILIGENSTEIN, RALF DITTMANN, THOMAS J. SPENCER, JOSEPH BIEDERMAN, JOACHIM WERNICKE, JEFFREY H. NEWCORN, CHARLES CASAT, DEN??I MILTON, and DAVID MICHELSON Journal of the American Academy of Child & Adolescent Psychiatry (2002) 41: 776 Link to Article | ||